MedWatch

GN chief after six years’ growth: time to expand

CEO Anders Hedegaard is both proud and satisfied that GN Hearing has increased its market share for the 24th quarter on the trod. He says he is ready to return to what made the company great in the first place: acquisitions.

Foto: GN Resound, PR

The second quarter of the year was another three months of growth for GN Store Nord’s hearing device unit, GN Hearing, and CEO Anders Hedegaard was naturally very pleased with a quarter in which the company once again usurped market shares.

“We’re in high spirits. We leave the second quarter with 12 percent growth and 10 percent organic growth in our hearing device segment. It’ s another quarter in which we steal market shares; we have done that for 24 quarters - or six years - running now. That makes us very proud in a highly competitive market,” Anders Hedegaard says in an interview with MedWatch.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

CHMP blåstempler ni nye lægemidler i maj

Den europæiske lægemiddelkomite, CHMP, har på dets møde i maj indstillet ni nye lægemidler til godkendelse samt anbefalet, at seks midler kan tages i brug på nye måder. To midler afvist.

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier